Immupharma (IMM) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Dec 2017 07:00 AM
RNS
Last patient completes dosing in LupuzorT Trial
28 Nov 2017 12:00 PM
RNS
Holding(s) in Company
24 Nov 2017 01:32 PM
RNS
Grant of Options
02 Nov 2017 07:00 AM
RNS
Update on LupuzorT Pivotal Phase III Study
16 Oct 2017 03:29 PM
RNS
Holding(s) in Company
04 Oct 2017 07:00 AM
RNS
Completion of Lanstead Sharing Agreement
27 Sep 2017 07:00 AM
RNS
Interim Results
26 Sep 2017 07:00 AM
RNS
Preparation of Lupuzor'sT Regulatory Submissions
21 Sep 2017 07:00 AM
RNS
Update on LupuzorT Pivotal Phase III Study
19 Sep 2017 07:00 AM
RNS
Notification of Interim Results
18 Aug 2017 05:09 PM
RNS
AIM Rule 17 Notice
12 Jul 2017 11:00 AM
RNS
Grant of Options
30 Jun 2017 12:04 PM
RNS
Result of AGM
30 Jun 2017 07:00 AM
RNS
Update on LupuzorT Pivotal Phase III Study
07 Jun 2017 07:00 AM
RNS
Annual Report & Notice of AGM
01 Jun 2017 07:00 AM
RNS
Final Results
22 May 2017 07:00 AM
RNS
Notification of Full Year Results
17 May 2017 07:00 AM
RNS
Update on Lupuzor Phase III Study
31 Mar 2017 10:17 AM
RNS
New Employee Share Option Plan & Grant of Options
31 Mar 2017 08:33 AM
RNS
New Employee Share Option Plan & Grant of Options
24 Mar 2017 07:00 AM
RNS
ImmuPharma to present at Master Investor Show
22 Mar 2017 08:51 AM
RNS
Holding(s) in Company
20 Mar 2017 11:41 AM
RNS
Holding(s) in Company
20 Mar 2017 07:00 AM
RNS
Holding(s) in Company
10 Mar 2017 03:52 PM
RNS
£4.1 Million Fund Raise via Accelerated Bookbuild
10 Mar 2017 07:00 AM
RNS
Accelerated Bookbuild for the Issue of Equity
06 Mar 2017 03:55 PM
RNS
Holding(s) in Company
17 Feb 2017 02:04 PM
RNS
Holding(s) in Company
25 Jan 2017 07:00 AM
RNS
Update on Lupuzor Phase III Study
24 Jan 2017 07:00 AM
RNS
Change of Adviser
29 Dec 2016 10:54 AM
RNS
Holding(s) in Company
22 Dec 2016 07:00 AM
RNS
Update on Lupuzor Pivotal Phase III Study
16 Nov 2016 07:00 AM
RNS
Update on Cancer Compound IPP-204106 'Nucant'
09 Nov 2016 07:00 AM
RNS
Holding(s) in Company
26 Oct 2016 03:42 PM
RNS
Holding(s) in Company
21 Oct 2016 05:13 PM
RNS
Close of Accelerated Bookbuild
21 Oct 2016 01:33 PM
RNS
Proposed Accelerated Bookbuild for Vendor Placing
30 Sep 2016 07:00 AM
RNS
Half-year Report
14 Sep 2016 07:00 AM
RNS
UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY
07 Sep 2016 07:00 AM
RNS
UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY
21 Jul 2016 08:32 AM
RNS
Holding(s) in Company
01 Jul 2016 03:52 PM
RNS
Holding(s) in Company
27 Jun 2016 04:41 PM
RNS
Second Price Monitoring Extn
27 Jun 2016 04:35 PM
RNS
Price Monitoring Extension
20 Jun 2016 07:00 AM
RNS
Appointment of Joint Broker
09 Jun 2016 05:56 PM
RNS
Holding(s) in Company
08 Jun 2016 07:00 AM
RNS
Symposium with Lupuzors Inventor Prof. S Muller
07 Jun 2016 07:00 AM
RNS
European Patients Commence Dosing in Lupuzor
02 Jun 2016 05:26 PM
RNS
Director/PDMR Shareholding
31 May 2016 10:38 AM
RNS
Holding(s) in Company
UK 100

Latest directors dealings